2.23  -0.04 (-1.76%)		04-19 16:00
Open: 2.25 High: 2.28 Volume: 30,518		Pre. Close: 2.27 Low: 2.21 Market Cap: 61(M)

Short term
Mid term
Targets	6-month :	3.29	1-year :	3.73
Resists	First :	2.82	Second :	3.2
Pivot price	2.49
Supports	First :	2.21	Second :	1.83
MAs	MA(5) :	2.3	MA(20) :	2.5
	MA(100) :	3.31	MA(250) :	3.3
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	3.2	D(3) :	4.8
RSI	RSI(14): 31.1
52-week	High :	4.63	Low :	0.34

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ MDXH ] has closed above bottom band by 19.8%. Bollinger Bands are 24.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	2.28 - 2.3	2.3 - 2.31
Low:	2.18 - 2.2	2.2 - 2.21
Close:	2.21 - 2.23	2.23 - 2.25

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Tue, 26 Mar 2024
MDXH Stock Quote Price and Forecast - CNN

Thu, 07 Mar 2024
These Analysts Increase Their Forecasts On MDxHealth After Q4 Results - Markets Insider

Wed, 06 Mar 2024
MDxHealth SA (MDXH) Q4 2023 Earnings Call Transcript - Seeking Alpha

Tue, 14 Nov 2023
MDxHealth to rise 1,000%, also to stay the same - yes, it’s complicated - Dhaka Tribune

Mon, 13 Nov 2023
MDxHealth Completes Reverse Stock Split - Orange County Business Journal

Thu, 05 Oct 2023
Why Investors Shouldn't Be Surprised By MDxHealth SA's (EBR:MDXH) 29% Share Price Plunge - Simply Wall St

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Shares Out	0 (M)
Shares Float	27 (M)
Held by Insiders	1.7e+007 (%)
Held by Institutions	2.6 (%)
Shares Short	20 (K)
Shares Short P.Month	0 (K)

EPS	-2.1
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.25
Profit Margin	-61.5 %
Operating Margin	-32.6 %
Return on Assets (ttm)	-13.8 %
Return on Equity (ttm)	-521.8 %
Qtrly Rev. Growth	50.5 %
Gross Profit (p.s.)	0
Sales Per Share	86105.8
EBITDA (p.s.)	-25111.6
Qtrly Earnings Growth	0 %
Operating Cash Flow	-22 (M)
Levered Free Cash Flow	-20 (M)

PE Ratio	-1.07
PEG Ratio	0
Price to Book value	8.57
Price to Sales	0
Price to Cash Flow	-0.01

Dividend	0
Forward Dividend	17070
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.